{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:17:52Z","timestamp":1791105472570,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2012,10,25]],"date-time":"2012-10-25T00:00:00Z","timestamp":1351123200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1038\/bjc.2012.473","type":"journal-article","created":{"date-parts":[[2012,10,25]],"date-time":"2012-10-25T22:57:23Z","timestamp":1351205843000},"page":"1815-1819","source":"Crossref","is-referenced-by-count":22,"title":["Efficacy of adjuvant aromatase inhibitor in hormone receptor-positive postmenopausal breast cancer patients according to the body mass index"],"prefix":"10.1038","volume":"107","author":[{"given":"M A N","family":"Sendur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Aksoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Zengin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Altundag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,25]]},"reference":[{"issue":"4","key":"BFbjc2012473_CR1","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1385\/MO:20:4:363","volume":"20","author":"R Abdah-Bortnyak","year":"2003","unstructured":"Abdah-Bortnyak R, Tsalic M, Haim N (2003) Actual body weight for determining doses of chemotherapy in obese cancer patients: evaluation of treatment tolerability. Med Oncol 20 (4): 363\u2013368","journal-title":"Med Oncol"},{"issue":"9324","key":"BFbjc2012473_CR2","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1016\/S0140-6736(02)09088-8","volume":"359","author":"M Baum","year":"2002","unstructured":"Baum M, Budzar AU, Cuzick J, Forbes J, Houghton JH, Klijn JG, Sahmoud T (2002) Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. Lancet 359 (9324): 2131\u20132139","journal-title":"Lancet"},{"issue":"9","key":"BFbjc2012473_CR3","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1002\/cncr.11745","volume":"98","author":"M Baum","year":"2003","unstructured":"Baum M, Buzdar A, Cuzick J, Forbes J, Houghton J, Howell A, Sahmoud T (2003) Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses. Cancer 98 (9): 1802\u20131810","journal-title":"Cancer"},{"issue":"2","key":"BFbjc2012473_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.tem.2011.10.003","volume":"23","author":"SE Bulun","year":"2012","unstructured":"Bulun SE, Chen D, Moy I, Brooks DC, Zhao H (2012) Aromatase, breast cancer and obesity: a complex interaction. Trends Endocrinol Metab 23 (2): 83\u201389","journal-title":"Trends Endocrinol Metab"},{"issue":"23","key":"BFbjc2012473_CR5","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1200\/JCO.2009.26.3756","volume":"28","author":"HJ Burstein","year":"2010","unstructured":"Burstein HJ, Prestrud AA, Seidenfeld J, Anderson H, Buchholz TA, Davidson NE, Gelmon KE, Giordano SH, Hudis CA, Malin J, Mamounas EP, Rowden D, Solky AJ, Sowers MR, Stearns V, Winer EP, Somerfield MR, Griggs JJ American Society of Clinical Oncology (2010) American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. J Clin Oncol 28 (23): 3784\u20133796","journal-title":"J Clin Oncol"},{"issue":"5","key":"BFbjc2012473_CR6","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1200\/JCO.2006.08.8617","volume":"25","author":"AS Coates","year":"2007","unstructured":"Coates AS, Keshaviah A, Th\u00fcrlimann B, Mouridsen H, Mauriac L, Forbes JF, Paridaens R, Castiglione-Gertsch M, Gelber RD, Colleoni M, L\u00e1ng I, Del Mastro L, Smith I, Chirgwin J, Nogaret JM, Pienkowski T, Wardley A, Jakobsen EH, Price KN, Goldhirsch A (2007) Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98. J Clin Oncol 25 (5): 486\u2013492","journal-title":"J Clin Oncol"},{"issue":"9491","key":"BFbjc2012473_CR7","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/S0140-6736(05)67110-3","volume":"366","author":"M Colleoni","year":"2005","unstructured":"Colleoni M, Li S, Gelber RD, Price KN, Coates AS, Castiglione-Gertsch M, Goldhirsch A International Breast Cancer Study Group (2005) Relation between chemotherapy dose, oestrogen receptor expression, and body-mass index. Lancet 366 (9491): 1108\u20131110","journal-title":"Lancet"},{"issue":"9561","key":"BFbjc2012473_CR8","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S0140-6736(07)60200-1","volume":"369","author":"RC Coombes","year":"2007","unstructured":"Coombes RC, Kilburn LS, Snowdon CF, Paridaens R, Coleman RE, Jones SE, Jassem J, Van de Velde CJ, Delozier T, Alvarez I, Del Mastro L, Ortmann O, Diedrich K, Coates AS, Bajetta E, Holmberg SB, Dodwell D, Mickiewicz E, Andersen J, L\u00f8nning PE, Cocconi G, Forbes J, Castiglione M, Stuart N, Stewart A, Fallowfield LJ, Bertelli G, Hall E, Bogle RG, Carpentieri M, Colajori E, Subar M, Ireland E, Bliss JM (2007) Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial. Lancet 369 (9561): 559\u2013570","journal-title":"Lancet"},{"issue":"1","key":"BFbjc2012473_CR9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10549-009-0512-0","volume":"119","author":"E de Azambuja","year":"2010","unstructured":"de Azambuja E, McCaskill-Stevens W, Francis P, Quinaux E, Crown JP, Vicente M, Giuliani R, Nordenskj\u00f6ld B, Guti\u00e9rez J, Andersson M, Vila MM, Jakesz R, Demol J, Dewar J, Santoro A, Lluch A, Olsen S, Gelber RD, Di Leo A, Piccart-Gebhart M (2010) The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial. Breast Cancer Res Treat 119 (1): 145\u2013153","journal-title":"Breast Cancer Res Treat"},{"issue":"17","key":"BFbjc2012473_CR10","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1200\/JCO.2010.31.6950","volume":"29","author":"MJ Ellis","year":"2011","unstructured":"Ellis MJ, Suman VJ, Hoog J, Lin L, Snider J, Prat A, Parker JS, Luo J, DeSchryver K, Allred DC, Esserman LJ, Unzeitig GW, Margenthaler J, Babiera GV, Marcom PK, Guenther JM, Watson MA, Leitch M, Hunt K, Olson JA (2011) Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50-based intrinsic subtype--ACOSOG Z1031. J Clin Oncol 29 (17): 2342\u20132349","journal-title":"J Clin Oncol"},{"issue":"24 Suppl","key":"BFbjc2012473_CR11","first-page":"208s","volume":"71","author":"RE Ellsworth","year":"2011","unstructured":"Ellsworth RE, Ellsworth CD, Shriver DL, Henry CD, Jackson M (2011) Effect of obesity on gene expression in invasive breast tumors. Cancer Res 71 (24 Suppl): 208s","journal-title":"Cancer Res"},{"issue":"24","key":"BFbjc2012473_CR12","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1200\/JCO.2012.42.0273","volume":"30","author":"EJ Folkerd","year":"2012","unstructured":"Folkerd EJ, Dixon JM, Renshaw L, A'hern RP, Dowsett M (2012) Suppression of plasma estrogen levels by letrozole and anastrozole is related to body mass index in patients with breast cancer. J Clin Oncol 30 (24): 2977\u20132980","journal-title":"J Clin Oncol"},{"issue":"1","key":"BFbjc2012473_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S1470-2045(07)70385-6","volume":"9","author":"JF Forbes","year":"2008","unstructured":"Forbes JF, Cuzick J, Buzdar A, Howell A, Tobias JS, Baum M (2008) Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. Lancet Oncol 9 (1): 45\u201353","journal-title":"Lancet Oncol"},{"issue":"3","key":"BFbjc2012473_CR14","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1200\/JCO.2002.20.3.751","volume":"20","author":"J Geisler","year":"2002","unstructured":"Geisler J, Haynes B, Anker G, Dowsett M, L\u00f8nning PE (2002) Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study. J Clin Oncol 20 (3): 751\u2013757","journal-title":"J Clin Oncol"},{"issue":"17","key":"BFbjc2012473_CR15","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1093\/jnci\/dji250","volume":"97","author":"PE Goss","year":"2005","unstructured":"Goss PE, Ingle JN, Martino S, Robert NJ, Muss HB, Piccart MJ, Castiglione M, Tu D, Shepherd LE, Pritchard KI, Livingston RB, Davidson NE, Norton L, Perez EA, Abrams JS, Cameron DA, Palmer MJ, Pater JL (2005) Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17. J Natl Cancer Inst 97 (17): 1262\u20131271","journal-title":"J Natl Cancer Inst"},{"issue":"13","key":"BFbjc2012473_CR16","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1200\/JCO.2011.39.9436","volume":"30","author":"JJ Griggs","year":"2012","unstructured":"Griggs JJ, Mangu PB, Anderson H, Balaban EP, Dignam JJ, Hryniuk WM, Morrison VA, Pini TM, Runowicz CD, Rosner GL, Shayne M, Sparreboom A, Sucheston LE, Lyman GH American Society of Clinical Oncology (2012) Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 30 (13): 1553\u20131561","journal-title":"J Clin Oncol"},{"issue":"1","key":"BFbjc2012473_CR17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/jnci\/djn415","volume":"101","author":"MJ Gunter","year":"2009","unstructured":"Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, Li J, Ho GY, Xue X, Anderson GL, Kaplan RC, Harris TG, Howard BV, Wylie-Rosett J, Burk RD, Strickler HD (2009) Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 101 (1): 48\u201360","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"BFbjc2012473_CR18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2217\/17455057.1.3.309","volume":"1","author":"A Howell","year":"2005","unstructured":"Howell A (2005) Anastrozole: a new gold standard of hormonal treatment for breast cancer? Womens Health (Lond Engl) 1 (3): 309\u2013322","journal-title":"Womens Health (Lond Engl)"},{"issue":"24 Suppl","key":"BFbjc2012473_CR19","first-page":"199s","volume":"71","author":"S Jiralerspong","year":"2011","unstructured":"Jiralerspong S, Wieand T, Rimawi MF, Nangia JR, Schiff R, Giordano SH, Pollak MN, Chenault CC, Osborne CK, Hilsenbeck SG (2011) Obesity, adjuvant therapy, and survival outcomes in early-stage breast cancer. Cancer Res 71 (24 Suppl): 199s","journal-title":"Cancer Res"},{"issue":"19","key":"BFbjc2012473_CR20","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1200\/JCO.2006.08.8054","volume":"25","author":"M Kaufmann","year":"2007","unstructured":"Kaufmann M, Jonat W, Hilfrich J, Eidtmann H, Gademann G, Zuna I, von Minckwitz G (2007) Improved overall survival in postmenopausal women with early breast cancer after anastrozole initiated after treatment with tamoxifen compared with continued tamoxifen: the ARNO 95 Study. J Clin Oncol 25 (19): 2664\u20132670","journal-title":"J Clin Oncol"},{"issue":"24 Suppl","key":"BFbjc2012473_CR21","first-page":"198s","volume":"71","author":"ML Kwan","year":"2011","unstructured":"Kwan ML, Chen WY, Weltzien E, Beasley JM, Lu W, Nechuta SJ, Quesenberry CP, Pierce JP, Shu XO, Caan BJ (2011) Pre-diagnosis body mass \u0131ndex and breast cancer prognosis and survival: report from the after Breast Cancer Pooling Project. Cancer Res 71 (24 Suppl): 198s","journal-title":"Cancer Res"},{"issue":"7","key":"BFbjc2012473_CR22","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1158\/1055-9965.EPI-05-0042","volume":"14","author":"S Loi","year":"2005","unstructured":"Loi S, Milne RL, Friedlander ML, McCredie MR, Giles GG, Hopper JL, Phillips KA (2005) Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 14 (7): 1686\u20131691","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"BFbjc2012473_CR23","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1023\/A:1020239211145","volume":"13","author":"LM Morimoto","year":"2002","unstructured":"Morimoto LM, White E, Chen Z, Chlebowski RT, Hays J, Kuller L, Lopez AM, Manson J, Margolis KL, Muti PC, Stefanick ML, McTiernan A (2002) Obesity, body size, and risk of postmenopausal breast cancer: the Women\u2019s Health Initiative (United States). Cancer Causes Control 13 (8): 741\u2013751","journal-title":"Cancer Causes Control"},{"issue":"8","key":"BFbjc2012473_CR24","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1056\/NEJMoa0810818","volume":"361","author":"H Mouridsen","year":"2009","unstructured":"Mouridsen H, Giobbie-Hurder A, Goldhirsch A, Th\u00fcrlimann B, Paridaens R, Smith I, Mauriac L, Forbes JF, Price KN, Regan MM, Gelber RD, Coates AS (2009) Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer. N Engl J Med 361 (8): 766\u2013776","journal-title":"N Engl J Med"},{"issue":"19","key":"BFbjc2012473_CR25","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1200\/JCO.2010.33.2585","volume":"29","author":"G Pfeiler","year":"2011","unstructured":"Pfeiler G, K\u00f6nigsberg R, Fesl C, Mlineritsch B, Stoeger H, Singer CF, P\u00f6stlberger S, Steger GG, Seifert M, Dubsky P, Taucher S, Samonigg H, Bjelic-Radisic V, Greil R, Marth C, Gnant M (2011) Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: an analysis of the prospective ABCSG-12 trial. J Clin Oncol 29 (19): 2653\u20132659","journal-title":"J Clin Oncol"},{"issue":"7630","key":"BFbjc2012473_CR26","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1136\/bmj.39367.495995.AE","volume":"335","author":"GK Reeves","year":"2007","unstructured":"Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D Million Women Study Collaboration (2007) Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 335 (7630): 1134","journal-title":"BMJ"},{"issue":"3","key":"BFbjc2012473_CR27","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1467-789X.2004.00142.x","volume":"5","author":"DP Rose","year":"2004","unstructured":"Rose DP, Komninou D, Stephenson GD (2004) Obesity, adipocytokines, and insulin resistance in breast cancer. Obes Rev 5 (3): 153\u2013165","journal-title":"Obes Rev"},{"issue":"21","key":"BFbjc2012473_CR28","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1200\/JCO.2009.27.2021","volume":"28","author":"I Sestak","year":"2010","unstructured":"Sestak I, Distler W, Forbes JF, Dowsett M, Howell A, Cuzick J (2010) Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial. J Clin Oncol 28 (21): 3411\u20133415","journal-title":"J Clin Oncol"},{"issue":"26","key":"BFbjc2012473_CR29","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1056\/NEJMoa052258","volume":"353","author":"B Th\u00fcrlimann","year":"2005","unstructured":"Th\u00fcrlimann B, Keshaviah A, Coates AS, Mouridsen H, Mauriac L, Forbes JF, Paridaens R, Castiglione-Gertsch M, Gelber RD, Rabaglio M, Smith I, Wardley A, Price KN, Goldhirsch A (2005) A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. N Engl J Med 353 (26): 2747\u20132757","journal-title":"N Engl J Med"},{"issue":"3","key":"BFbjc2012473_CR30","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s10549-011-1874-7","volume":"131","author":"R Wolters","year":"2012","unstructured":"Wolters R, Schwentner L, Regierer A, Wischnewsky M, Kreienberg R, W\u00f6ckel A (2012) Endocrine therapy in obese patients with primary breast cancer: another piece of evidence in an unfinished puzzle. Breast Cancer Res Treat 131 (3): 925\u2013931","journal-title":"Breast Cancer Res Treat"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2012473.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2012473","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2012473.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:11:30Z","timestamp":1684415490000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2012473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,25]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["BFbjc2012473"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2012.473","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,25]]}}}